Article
Assessment of the incremental value of recombinant thyrotropin stimulation before 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging to localize residual differentiated thyroid cancer.
The Journal of clinical endocrinology and metabolism - 1 Apr 2009
Leboulleux S, Schroeder P R, Busaidy N L, Auperin A, Corone C, Jacene H A, Ewertz M E, Bournaud C, Wahl R L, Sherman S I, Ladenson P W, Schlumberger M
Abstract excerpt
PURPOSE: The purpose of the study was to assess prospectively the impact of recombinant human TSH (rhTSH) administration on positron emission tomography (PET)/computed tomography (CT) imaging in differentiated thyroid cancer patients who, after primary treatment, had a suppressed or stimulated serum thyroglobulin greater than 10 ng/ml and no radioactive iodine uptake consistent with thyroid cancer on a whole body...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.